91678-23-8 Usage
General Description
2-Bromo-6-chloro-3-nitropyridine is a chemical compound with the molecular formula C5H3BrClN2O2. It is a nitropyridine derivative that contains bromine and chlorine as substituents on the pyridine ring. The compound is commonly used as an intermediate in the synthesis of various pharmaceuticals, agrochemicals, and dyes. It is known for its ability to undergo various chemical reactions, including substitution, addition, and reduction, making it a versatile building block in organic synthesis. Additionally, 2-Bromo-6-chloro-3-nitropyridine is considered to be a potential environmental contaminant, and precautions should be taken to handle and dispose of it safely.
Check Digit Verification of cas no
The CAS Registry Mumber 91678-23-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,1,6,7 and 8 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 91678-23:
(7*9)+(6*1)+(5*6)+(4*7)+(3*8)+(2*2)+(1*3)=158
158 % 10 = 8
So 91678-23-8 is a valid CAS Registry Number.
InChI:InChI=1/C5H2BrClN2O2/c6-5-3(9(10)11)1-2-4(7)8-5/h1-2H
91678-23-8Relevant articles and documents
Organic electroluminescent material and device thereof
-
Paragraph 0126-0129, (2020/09/30)
Disclosed are an organic electroluminescent material and a device thereof. The organic electroluminescent material is a novel triaryl amine-aza-carbazole quinazoline compound. The compound is used asa host material in an electroluminescent device and prov
ALKYNYL ALCOHOLS AND METHODS OF USE
-
Paragraph 0575; 0576, (2015/03/04)
The invention relates to compounds of Formula (0): wherein A1-A8, R4 and R5 each has the meaning as described herein. Compounds of Formula (0) and pharmaceutical compositions thereof are useful in the treatment of diseases and disorders in which undesired or over-activation of NF-kB signaling is observed.
Heterobicyclic amide compounds
-
Page/Page column 10, (2010/11/28)
Compounds of formula I processes for their preparation and pharmaceutical compositions comprising them.
